Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review

INTRODUCTION: Globally about 1.7 million children were living with HIV in 2020. Two integrase strand transfer inhibitors, dolutegravir and raltegravir, are increasingly used in children. We conducted a systematic review to assess the effectiveness and safety of dolutegravir and raltegravir in childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Claire L., O'Rourke, John, Milanzi, Edith, Collins, Intira Jeannie, Judd, Ali, Castro, Hannah, Vicari, Marissa, Jesson, Julie, Leroy, Valériane, Renaud, Françoise, Penazzato, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663860/
https://www.ncbi.nlm.nih.gov/pubmed/36377082
http://dx.doi.org/10.1002/jia2.25970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663860/
https://www.ncbi.nlm.nih.gov/pubmed/36377082
http://dx.doi.org/10.1002/jia2.25970

Ejemplares similares